BACKGROUND :
Bleeding after endoscopic submucosal dissection (ESD) is a severe adverse event. Several methods to prevent post-ESD
bleeding (PEB) have been introduced; however, they have not been widely used because of technical difficulties. We aimed to investigate whether
polysaccharide hemostatic powder (PHP), which is very easy to apply, can prevent early post-ESD
bleeding, especially in patients with a high risk of post-ESD
bleeding. METHODS : This was a prospective, multicenter, randomized, open-label, controlled trial. Patients with a high risk for post-ESD
bleeding were enrolled. Patients with
gastric neoplasms in whom the resected specimen size was expected to be > 40 mm and those who were regularly taking
antithrombotic agents were defined as high risk patients. Patients were randomly assigned to the PHP or control groups. RESULTS: Between May 2017 and September 2018, 143 patients were enrolled (PHP group, 73; control group, 70). The total post-ESD
bleeding rate was 6.3 % (PHP group, 5.5 % vs. control group, 7.1 %; P = 0.74). There was no
bleeding within 7 days after ESD in the PHP group. Continued antithrombotic use was an independent risk factor for post-ESD
bleeding. In subgroup analysis excluding the patients who continued to take
antithrombotic agents (n = 129) during ESD, the rate of post-ESD
bleeding tended to be lower in the PHP group than in the control group (0 % vs. 6.3 %; P = 0.06). CONCLUSION : PHP did not demonstrate a significant effect on the prevention of post-ESD
bleeding in this study. Further larger scale, randomized controlled trials are needed to confirm this.